{
    "id": 30514,
    "fullName": "EGFR N771_P772insL",
    "impact": "insertion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR N771_P772insL results in the insertion of one amino acids in the protein kinase domain of the Egfr protein between amino acids 771 and 772 (UniProt.org). N771_P772insL has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other Egfr exon 20 insertion mutations (PMID: 24353160).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 440,
                    "pubMedId": 24353160,
                    "title": "Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24353160"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "N771_P772insL",
    "createDate": "07/16/2019",
    "updateDate": "07/16/2019",
    "referenceTranscriptCoordinates": {
        "id": 180899,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181323_55181324insTTC",
        "cDna": "c.2314_2315insTTC",
        "protein": "p.N771_P772insL",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 17640,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Tagrisso (osimertinib) treatment resulted in stable disease with a progression-free survival of 4.9 months in a patient with non-small cell lung cancer harboring EGFR N771_P772insL (PMID: 31208370).",
            "molecularProfile": {
                "id": 32708,
                "profileName": "EGFR N771_P772insL"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15706,
                    "pubMedId": 31208370,
                    "title": "EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31208370"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32708,
            "profileName": "EGFR N771_P772insL",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 180899,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181323_55181324insTTC",
            "cDna": "c.2314_2315insTTC",
            "protein": "p.N771_P772insL",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}